Novo Nordisk AS
A3EU6F
DK0062498333 //
Quelle: CPH Equities: 13.10.2026, 19:03:36
256,65 DKK
Kurs
Kurs
0,10%
Diff. Vortag in %
Diff. Vortag in %
224,25 DKK
52 Wochen Tief
52 Wochen Tief
409,95 DKK
52 Wochen Hoch
52 Wochen Hoch
- Neutral
- Seit dem 25.09.2026
- Informationen von thescreener.com
Tools
Fundamentalanalyse
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 0 Monate | 0 Monate | 256,65 225 | 256,65 | 225 | 12,33197 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 05.10.2026 0 Monate | 05.10.2026 | 0 Monate | 256,65 275 | 256,65 | 275 | 7,149815 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 256,65 245 | 256,65 | 245 | 4,539256 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 256,65 245 | 256,65 | 245 | 4,539256 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 22.09.2026 12 Monate | 22.09.2026 | 12 Monate | 256,65 305 | 256,65 | 305 | 18,838886 | BERENBERG | ||
| Novo Nordisk AS | 21.09.2026 12 Monate | 21.09.2026 | 12 Monate | 256,65 285 | 256,65 | 285 | 11,046172 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 21.09.2026 0 Monate | 21.09.2026 | 0 Monate | 256,65 275 | 256,65 | 275 | 7,149815 | JPMORGAN | ||
| Novo Nordisk AS | 21.09.2026 12 Monate | 21.09.2026 | 12 Monate | 256,65 275 | 256,65 | 275 | 7,149815 | JEFFERIES | ||
| Novo Nordisk AS | 21.09.2026 0 Monate | 21.09.2026 | 0 Monate | 256,65 260 | 256,65 | 260 | 1,30528 | JPMORGAN | ||
| Novo Nordisk AS | 21.09.2026 0 Monate | 21.09.2026 | 0 Monate | 256,65 332 | 256,65 | 332 | 29,359049 | UBS | ||
| Novo Nordisk AS | 16.09.2026 0 Monate | 16.09.2026 | 0 Monate | 256,65 332 | 256,65 | 332 | 29,359049 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 256,65 265 | 256,65 | 265 | 3,253458 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 11.09.2026 12 Monate | 11.09.2026 | 12 Monate | 256,65 250 | 256,65 | 250 | 2,591077 | MORGAN STANLEY | ||
| Novo Nordisk AS | 07.09.2026 12 Monate | 07.09.2026 | 12 Monate | 256,65 300 | 256,65 | 300 | 16,890707 | BARCLAYS | ||
| Novo Nordisk AS | 03.09.2026 0 Monate | 03.09.2026 | 0 Monate | 256,65 275 | 256,65 | 275 | 7,149815 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 256,65 265 | 256,65 | 265 | 3,253458 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 256,65 265 | 256,65 | 265 | 3,253458 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 12 Monate | 12 Monate | 256,65 290 | 256,65 | 290 | 12,99435 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 24.08.2026 0 Monate | 24.08.2026 | 0 Monate | 256,65 275 | 256,65 | 275 | 7,149815 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 256,65 290 | 256,65 | 290 | 12,99435 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.08.2026 0 Monate | 11.08.2026 | 0 Monate | 256,65 305 | 256,65 | 305 | 18,838886 | BERENBERG | ||
| Novo Nordisk AS | 07.08.2026 0 Monate | 07.08.2026 | 0 Monate | 256,65 | 256,65 | -- | DZ BANK | |||
| Novo Nordisk AS | 06.08.2026 12 Monate | 06.08.2026 | 12 Monate | 256,65 285 | 256,65 | 285 | 11,046172 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.08.2026 12 Monate | 06.08.2026 | 12 Monate | 256,65 290 | 256,65 | 290 | 12,99435 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 05.08.2026 0 Monate | 05.08.2026 | 0 Monate | 256,65 200 | 256,65 | 200 | 22,072862 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 05.08.2026 0 Monate | 05.08.2026 | 0 Monate | 256,65 332 | 256,65 | 332 | 29,359049 | UBS | ||
| Novo Nordisk AS | 05.08.2026 12 Monate | 05.08.2026 | 12 Monate | 256,65 310 | 256,65 | 310 | 20,787064 | BARCLAYS | ||
| Novo Nordisk AS | 04.08.2026 12 Monate | 04.08.2026 | 12 Monate | 256,65 285 | 256,65 | 285 | 11,046172 | JEFFERIES | ||
| Novo Nordisk AS | 04.08.2026 0 Monate | 04.08.2026 | 0 Monate | 256,65 332 | 256,65 | 332 | 29,359049 | UBS | ||
| Novo Nordisk AS | 31.07.2026 0 Monate | 31.07.2026 | 0 Monate | 256,65 250 | 256,65 | 250 | 2,591077 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 256,65 290 | 256,65 | 290 | 12,99435 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 10.07.2026 0 Monate | 10.07.2026 | 0 Monate | 256,65 332 | 256,65 | 332 | 29,359049 | UBS | ||
| Novo Nordisk AS | 29.06.2026 12 Monate | 29.06.2026 | 12 Monate | 256,65 285 | 256,65 | 285 | 11,046172 | JEFFERIES | ||
| Novo Nordisk AS | 28.06.2026 0 Monate | 28.06.2026 | 0 Monate | 256,65 250 | 256,65 | 250 | 2,591077 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 256,65 290 | 256,65 | 290 | 12,99435 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 16.06.2026 0 Monate | 16.06.2026 | 0 Monate | 256,65 325 | 256,65 | 325 | 26,631599 | BERENBERG |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 0 Monate | 0 Monate | 256,65 290 | 256,65 | 290 | 12,99435 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 08.06.2026 0 Monate | 08.06.2026 | 0 Monate | 256,65 250 | 256,65 | 250 | 2,591077 | JPMORGAN | ||
| Novo Nordisk AS | 08.06.2026 0 Monate | 08.06.2026 | 0 Monate | 256,65 250 | 256,65 | 250 | 2,591077 | JPMORGAN | ||
| Novo Nordisk AS | 03.06.2026 12 Monate | 03.06.2026 | 12 Monate | 256,65 305 | 256,65 | 305 | 18,838886 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 29.05.2026 0 Monate | 29.05.2026 | 0 Monate | 256,65 270 | 256,65 | 270 | 5,201636 | JEFFERIES | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 256,65 290 | 256,65 | 290 | 12,99435 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 256,65 290 | 256,65 | 290 | 12,99435 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 18.05.2026 0 Monate | 18.05.2026 | 0 Monate | 256,65 300 | 256,65 | 300 | 16,890707 | BARCLAYS | ||
| Novo Nordisk AS | 12.05.2026 12 Monate | 12.05.2026 | 12 Monate | 256,65 270 | 256,65 | 270 | 5,201636 | JEFFERIES | ||
| Novo Nordisk AS | 11.05.2026 12 Monate | 11.05.2026 | 12 Monate | 256,65 175 | 256,65 | 175 | 31,813754 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 256,65 290 | 256,65 | 290 | 12,99435 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 256,65 290 | 256,65 | 290 | 12,99435 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 256,65 | 256,65 | -- | DZ BANK | |||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 256,65 300 | 256,65 | 300 | 16,890707 | BARCLAYS | ||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 256,65 332 | 256,65 | 332 | 29,359049 | UBS | ||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 256,65 250 | 256,65 | 250 | 2,591077 | JPMORGAN | ||
| Novo Nordisk AS | 06.05.2026 12 Monate | 06.05.2026 | 12 Monate | 256,65 263 | 256,65 | 263 | 2,474187 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 256,65 250 | 256,65 | 250 | 2,591077 | JPMORGAN | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 256,65 175 | 256,65 | 175 | 31,813754 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 256,65 300 | 256,65 | 300 | 16,890707 | BARCLAYS | ||
| Novo Nordisk AS | 29.04.2026 12 Monate | 29.04.2026 | 12 Monate | 256,65 250 | 256,65 | 250 | 2,591077 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 256,65 275 | 256,65 | 275 | 7,149815 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 256,65 270 | 256,65 | 270 | 5,201636 | JEFFERIES | ||
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 256,65 250 | 256,65 | 250 | 2,591077 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 15.04.2026 12 Monate | 15.04.2026 | 12 Monate | 256,65 270 | 256,65 | 270 | 5,201636 | JEFFERIES | ||
| Novo Nordisk AS | 09.04.2026 0 Monate | 09.04.2026 | 0 Monate | 256,65 332 | 256,65 | 332 | 29,359049 | UBS | ||
| Novo Nordisk AS | 01.04.2026 0 Monate | 01.04.2026 | 0 Monate | 256,65 270 | 256,65 | 270 | 5,201636 | BARCLAYS | ||
| Novo Nordisk AS | 31.03.2026 12 Monate | 31.03.2026 | 12 Monate | 256,65 263 | 256,65 | 263 | 2,474187 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 30.03.2026 0 Monate | 30.03.2026 | 0 Monate | 256,65 270 | 256,65 | 270 | 5,201636 | BARCLAYS | ||
| Novo Nordisk AS | 29.03.2026 0 Monate | 29.03.2026 | 0 Monate | 256,65 250 | 256,65 | 250 | 2,591077 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 256,65 275 | 256,65 | 275 | 7,149815 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.03.2026 0 Monate | 26.03.2026 | 0 Monate | 256,65 270 | 256,65 | 270 | 5,201636 | BARCLAYS | ||
| Novo Nordisk AS | 25.03.2026 0 Monate | 25.03.2026 | 0 Monate | 256,65 250 | 256,65 | 250 | 2,591077 | JPMORGAN | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 256,65 270 | 256,65 | 270 | 5,201636 | JEFFERIES | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 256,65 270 | 256,65 | 270 | 5,201636 | BARCLAYS | ||
| Novo Nordisk AS | 11.03.2026 0 Monate | 11.03.2026 | 0 Monate | 256,65 300 | 256,65 | 300 | 16,890707 | BERENBERG |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 09.03.2026 0 Monate | 09.03.2026 | 0 Monate | 256,65 250 | 256,65 | 250 | 2,591077 | JPMORGAN | ||
| Novo Nordisk AS | 06.03.2026 12 Monate | 06.03.2026 | 12 Monate | 256,65 270 | 256,65 | 270 | 5,201636 | BARCLAYS | ||
| Novo Nordisk AS | 02.03.2026 12 Monate | 02.03.2026 | 12 Monate | 256,65 260 | 256,65 | 260 | 1,30528 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 02.03.2026 0 Monate | 02.03.2026 | 0 Monate | 256,65 270 | 256,65 | 270 | 5,201636 | BARCLAYS | ||
| Novo Nordisk AS | 27.02.2026 12 Monate | 27.02.2026 | 12 Monate | 256,65 270 | 256,65 | 270 | 5,201636 | BARCLAYS | ||
| Novo Nordisk AS | 24.02.2026 12 Monate | 24.02.2026 | 12 Monate | 256,65 400 | 256,65 | 400 | 55,854276 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.02.2026 0 Monate | 24.02.2026 | 0 Monate | 256,65 250 | 256,65 | 250 | 2,591077 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 256,65 400 | 256,65 | 400 | 55,854276 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 256,65 332 | 256,65 | 332 | 29,359049 | UBS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 256,65 340 | 256,65 | 340 | 32,476135 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 256,65 275 | 256,65 | 275 | 7,149815 | JEFFERIES | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 256,65 350 | 256,65 | 350 | 36,372492 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 256,65 340 | 256,65 | 340 | 32,476135 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 256,65 275 | 256,65 | 275 | 7,149815 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 256,65 250 | 256,65 | 250 | 2,591077 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 256,65 270 | 256,65 | 270 | 5,201636 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 256,65 340 | 256,65 | 340 | 32,476135 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 256,65 340 | 256,65 | 340 | 32,476135 | BARCLAYS | ||
| Novo Nordisk AS | 17.02.2026 0 Monate | 17.02.2026 | 0 Monate | 256,65 340 | 256,65 | 340 | 32,476135 | BARCLAYS | ||
| Novo Nordisk AS | 12.02.2026 0 Monate | 12.02.2026 | 0 Monate | 256,65 340 | 256,65 | 340 | 32,476135 | BARCLAYS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 256,65 400 | 256,65 | 400 | 55,854276 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 256,65 275 | 256,65 | 275 | 7,149815 | JEFFERIES | ||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 256,65 360 | 256,65 | 360 | 40,268849 | BERENBERG | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 256,65 360 | 256,65 | 360 | 40,268849 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 256,65 360 | 256,65 | 360 | 40,268849 | BARCLAYS | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 256,65 350 | 256,65 | 350 | 36,372492 | JPMORGAN | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 256,65 332 | 256,65 | 332 | 29,359049 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 256,65 475 | 256,65 | 475 | 85,076953 | DEUTSCHE BANK RESEARCH |
News
Aktuell
| Datum | Terminart Information | Information |
|---|---|---|
| 04.11.2026 | Bericht zum 3. Quartal Novo Nordisk A/S: Third quarter 2026 | Novo Nordisk A/S: Third quarter 2026 |
Anlage-Spezial Europäische Aktien
28.05.2026
Novo Nordisk: KI und Amycretin zünden nächste Pipeline-Stufe
KI beschleunigt die Wirkstoffforschung von Novo Nordisk erheblich. Neue Tabletten wie Amycretin sichern dabei die künftige Marktdominanz ab.
DZ BANK Produktauswahl
Optionsscheine Classic Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
Abstand zum Basispreis in %
Max
Discount Classic
Produktauswahl : Basiswert Novo Nordisk AS
Min
Discount in %
Max
Endlos Turbos Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Optionsscheine Classic Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
Abstand zum Basispreis in %
Max
Endlos Turbos Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Knock Out Map
- wertpapiere@dzbank.de (069) 7447-7035
-
DZ BANK AG, Platz der Republik,
60265 Frankfurt / M